scispace - formally typeset
O

Orsolya Galamb

Researcher at Hungarian Academy of Sciences

Publications -  89
Citations -  1939

Orsolya Galamb is an academic researcher from Hungarian Academy of Sciences. The author has contributed to research in topics: Colorectal cancer & DNA methylation. The author has an hindex of 24, co-authored 85 publications receiving 1638 citations. Previous affiliations of Orsolya Galamb include Semmelweis University.

Papers
More filters
Journal ArticleDOI

Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature.

TL;DR: Using routine biopsy samples, whole genomic microarray analysis was successfully performed to identify discriminative signatures and provide further insight into the pathophysiological background of colonic diseases.
Journal ArticleDOI

Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon

TL;DR: A role for transforming growth factor-β and its downstream Smad signaling, the phosphatidylinositol 3'-kinase/Akt/mTOR axis, the Ras-mitogen-activated protein kinase/Snail/Slug and FOXC2 pathway, and Hedgehog signaling and microRNAs in the development of colorectal cancers via epithelial-to-mesenchymal transition are discussed.
Journal ArticleDOI

Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples

TL;DR: A panel of biomarkers with altered methylation along the colorectal adenoma-carcinoma sequence in both colonic tissue and plasma is developed, suggesting that this methylation biomarker panel allows non-invasive detection of colorectors adenomas and cancer from plasma samples.
Journal ArticleDOI

Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results

TL;DR: Whole genomic microarray analysis using routine biopsy samples is suitable for the identification of discriminative signatures for differential diagnostic purposes and may be the basis for new GEP-based diagnostic methods.
Journal ArticleDOI

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

TL;DR: N-(2-cyclohexyloxy-4-nitrophenyl)-methanesulfonamide has a reversal effect on the expression of several genes that altered in colorectal adenoma–carcinoma sequence, and more efficiently inverted the expression changes seen in the normal-adenoma than in thenormal-cARCinoma transition.